Cargando…

Clinical Utility and Application of Liquid Biopsy Genotyping in Lung Cancer: A Comprehensive Review

Precision medicine has revolutionized the therapeutic management of cancer patients with a major impact on non-small cell lung cancer (NSCLC), particularly lung adenocarcinoma, where advances have been remarkable. Tissue biopsy, required for tumor molecular testing, has significant limitations due t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nigro, Maria Concetta, Marchese, Paola Valeria, Deiana, Chiara, Casadio, Chiara, Galvani, Linda, Di Federico, Alessandro, De Giglio, Andrea
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9904307/ https://www.ncbi.nlm.nih.gov/pubmed/36762267 http://dx.doi.org/10.2147/LCTT.S388047

Ejemplares similares

Liquid biopsy genotyping in lung cancer: ready for clinical utility?
por: Huang, Wei-Lun, et al.
Publicado: (2017)

Bone-specific response according to MDA criteria predicts immunotherapy efficacy among advanced non-small cell lung cancer (NSCLC) patients
por: De Giglio, Andrea, et al.
Publicado: (2022)

Advanced non-small-cell lung cancer: how to manage non-oncogene disease
por: De Giglio, Andrea, et al.
Publicado: (2022)

Liquid Biopsy in Rare Cancers: Lessons from Hemangiopericytoma
por: Nicolazzo, Chiara, et al.
Publicado: (2018)

The Landscape of Immunotherapy in Advanced NSCLC: Driving Beyond PD-1/PD-L1 Inhibitors (CTLA-4, LAG3, IDO, OX40, TIGIT, Vaccines)
por: De Giglio, Andrea, et al.
Publicado: (2021)

Methylation Markers in Cutaneous Melanoma: Unravelling the Potential Utility of Their Tracking by Liquid Biopsy
por: Aleotti, Valentina, et al.
Publicado: (2021)

Liquid Biopsy, an Everchanging Balance between Clinical Utility and Emerging Technologies
por: Cucciniello, Linda, et al.
Publicado: (2022)

Are FGFR and IDH1-2 alterations a positive prognostic factor in intrahepatic cholangiocarcinoma? An unresolved issue
por: Brandi, Giovanni, et al.
Publicado: (2023)

Liquid biopsies and cancer omics
por: Amelio, Ivano, et al.
Publicado: (2020)

Liquid biopsy in lymphoma
por: Rossi, Davide, et al.
Publicado: (2019)

Evolving Clinical Utility of Liquid Biopsy in Gastrointestinal Cancers
por: Jacobson, Richard A., et al.
Publicado: (2019)

Translational Utility of Liquid Biopsies in Thyroid Cancer Management
por: Wijewardene, Ayanthi A., et al.
Publicado: (2021)

Potential clinical utility of liquid biopsies in ovarian cancer
por: Zhu, Jie Wei, et al.
Publicado: (2022)

Opportunities and Challenges of Liquid Biopsy in Thyroid Cancer
por: Romano, Chiara, et al.
Publicado: (2021)

Liquid biopsy in hematological malignancies: current and future applications
por: Talotta, Donatella, et al.
Publicado: (2023)

The Utility of Repetitive Cell-Free DNA in Cancer Liquid Biopsies
por: Gezer, Ugur, et al.
Publicado: (2022)

Potential utility of miRNAs for liquid biopsy in breast cancer
por: Liu, Xiangrong, et al.
Publicado: (2022)

Liquid Biopsy Detecting Circulating Tumor Cells in Patients with Non-Small Cell Lung Cancer: Preliminary Results of a Pilot Study
por: Mastromarino, Maria Giovanna, et al.
Publicado: (2023)

Introduction and utility of liquid-based cytology on aspiration biopsy of peripheral nodular lesions of the lung
por: IMURA, JOHJI, et al.
Publicado: (2014)

The liquid biopsy in lung cancer
por: Ansari, Junaid, et al.
Publicado: (2016)

Liquid Biopsies in Lung Cancer
por: Kemper, Marcel, et al.
Publicado: (2023)

Case Report: The Added Value of Liquid Biopsy in Advanced Colorectal Cancer From Clinical Case Experiences
por: Ulivi, Paola, et al.
Publicado: (2021)

Molecular identification of bronchopulmonary neuroendocrine tumours and neuroendocrine genotype in lung neoplasia using the NETest liquid biopsy
por: Filosso, Pier Luigi, et al.
Publicado: (2020)

Prostate Cancer Liquid Biopsy Biomarkers’ Clinical Utility in Diagnosis and Prognosis
por: Matuszczak, Milena, et al.
Publicado: (2021)

Utility of liquid biopsy in diagnosing isolated cerebral phaeohyphomycosis: illustrative case
por: Arrighi-Allisan, Annie E., et al.
Publicado: (2022)

Potential utility of risk stratification for multicancer screening with liquid biopsy tests
por: Kim, Elle S., et al.
Publicado: (2023)

Liquid Biopsy in Colorectal Cancer: Quo Vadis? Implementation of Liquid Biopsies in Routine Clinical Patient Care in Two German Comprehensive Cancer Centers
por: Fischer, Laura E., et al.
Publicado: (2022)

Potential clinical utility of liquid biopsy in early-stage non-small cell lung cancer
por: Shen, Haifeng, et al.
Publicado: (2022)

Use of bronchoscopic steam thermal ablation (BTVA) in a clinically compromised patient
por: Marchese, Roberto, et al.
Publicado: (2022)

Liquid biopsy for lung cancer immunotherapy
por: Cai, Liang-Liang, et al.
Publicado: (2019)

Liquid biopsy in lung cancer management
por: Irofei Zamfir, Maria-Anca, et al.
Publicado: (2022)

Integrating Liquid Biopsy and Radiomics to Monitor Clonal Heterogeneity of EGFR-Positive Non-Small Cell Lung Cancer
por: Cucchiara, Federico, et al.
Publicado: (2020)

Liquid Biopsies in Cancer Diagnosis, Monitoring and Prognosis
por: Ulivi, Paola, et al.
Publicado: (2022)

Utility of “liquid biopsy” using pancreatic juice for early detection of pancreatic cancer
por: Okada, Tetsuhiro, et al.
Publicado: (2018)

Limited Practical Utility of Liquid Biopsy in the Treated Patients with Advanced Breast Cancer
por: Niwinska, Anna, et al.
Publicado: (2020)

Clinical utility of liquid biopsy-based companion diagnostics in the non-small-cell lung cancer treatment
por: Sato, Yoshiharu
Publicado: (2022)

Absolute Quantification of Choline-Related Biomarkers in Breast Cancer Biopsies by Liquid Chromatography Electrospray Ionization Mass Spectrometry
por: Mimmi, Maria Chiara, et al.
Publicado: (2013)

Liquid Biopsy and Cancer: An Ongoing Story
por: Di Zazzo, Erika, et al.
Publicado: (2023)

RAS Mutation Conversion in Bevacizumab-Treated Metastatic Colorectal Cancer Patients: A Liquid Biopsy Based Study
por: Nicolazzo, Chiara, et al.
Publicado: (2022)

Malignant pleural effusion supernatant is an alternative liquid biopsy specimen for comprehensive mutational profiling
por: Guo, Zhihua, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_dnbddfr2flp917suqbq1mnciir